Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Obesity and associated metabolic complications, such as non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D), are in constant increase around the world. While most obese patients show several metabolic and biometric abnormalities and comorbidities, a subgroup of patients representing 3% to 57% of obese adults, depending on the diagnosis criteria, remains metabolically healthy. Among many other factors, the gut microbiota is now identified as a determining factor in the pathogenesis of metabolically unhealthy obese (MUHO) individuals and in obesity-related diseases such as endotoxemia, intestinal and systemic inflammation, as well as insulin resistance. Interestingly, recent studies suggest that an optimal healthy-like gut microbiota structure may contribute to the metabolically healthy obese (MHO) phenotype. Here, we describe how dietary medium chain triglycerides (MCT), previously found to promote lipid catabolism, energy expenditure and weight loss, can ameliorate metabolic health via their capacity to improve both intestinal ecosystem and permeability. MCT-enriched diets could therefore be used to manage metabolic diseases through modification of gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048 · cited 4×
“An optimal gut microbiota helps maintain intestinal barrier impermeability via the production of SCFA, which serve as metabolic precursors for colonocytes in normal physiologic hypoxia conditions [47–49].”
BackgroundInfluentialCani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · cited 1×
“The transplantation of fecal microbiota from obese mice and obese patients into germ-free lean mice transformed the lean mice into obese mice, while the germ-free mice receiving microbiota from lean mice did not show any metabolic symptoms related to obesity or insulin resistance [54,75–77].”
Haslam, D. W., & James, W. P. T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67483-1 · Cited by 3,757
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice
Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E., Knight, R., & Gordon, J. I. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000322 · Cited by 3,058 · cited 1×
“The transplantation of fecal microbiota from obese mice and obese patients into germ-free lean mice transformed the lean mice into obese mice, while the germ-free mice receiving microbiota from lean mice did not show any metabolic symptoms related to obesity or insulin resistance [54,75–77].”
BackgroundMechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615 · cited 2×
“Backhed and colleagues first demonstrated that germ-free mice were protected against high fat and high sugar diet-induced obesity, via enhanced expression of hepatic and muscular Pgc-1α (a PPAR coactivator) and activation of lipid catabolism via AMPK activity [56].”
BackgroundCani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 1×
“A dysbiosis induced by obesogenic factors adversely enhances intestinal permeability by modulating the expression of epithelial junction genes zo-1 and occludin [63,64].”
BackgroundObesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100 · cited 4×
“This pathology is associated with an elevated waist circumference, a progressive state of non-alcoholic fatty liver disease (NAFLD) [3,4], insulin resistance, type 2 diabetes (T2D), some types of cancers (especially in women), hypertension, cardiovascular diseases, reproductive abnormalities, dyslipidemias, psychologi…”
BackgroundInfluentialKelly, C. J., Zheng, L., Campbell, E. L., Saeedi, B., Scholz, C. C., Bayless, A. J., Wilson, K. E., Glover, L. E., Kominsky, D. J., Magnuson, A., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.005 · Cited by 1,716 · cited 1×
“These SCFA were recently found to promote intestinal impermeability [47] as well as hepatic sugar and lipid anabolism [48–50].”
BackgroundWildman, R. P. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1617 · Cited by 1,618
Bacteria as vitamin suppliers to their host: A gut microbiota perspective
LeBlanc, J. G., Milani, C., de Giori, G. S., Sesma, F., van Sinderen, D., & Ventura, M. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2012.08.005 · Cited by 1,613 · cited 1×
“The gut microbiota is also an indispensable source of essential vitamins B and K [51].”
BackgroundDifferential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss
Furet, J.-P., Kong, L.-C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.-L., Mariat, D., Corthier, G., Doré, J., Henegar, C., et al. (2010) · Diabetes · doi:10.2337/db10-0253 · Cited by 1,173
Medium-chain triglycerides: an update
Bach, A., & Babayan, V. (1982) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.950 · Cited by 1,151 · cited 2×
“Large amounts of MCFA are found, in the form of MCT, in coconut and palm kernel oils where they account for more than 50% of total lipids [102,103].”
BackgroundThe Human Obesity Gene Map: The 2005 Update
Rankinen, T., Zuberi, A., Chagnon, Y. C., Weisnagel, S. J., Argyropoulos, G., Walts, B., Pérusse, L., & Bouchard, C. (2006) · Obesity · doi:10.1038/oby.2006.71 · Cited by 1,119
Grundy, S. M. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.10.004 · Cited by 882
Ten Putative Contributors to the Obesity Epidemic
McAllister, E. J., Dhurandhar, N. V., Keith, S. W., Aronne, L. J., Barger, J., Baskin, M., Benca, R. M., Biggio, J., Boggiano, M. M., Eisenmann, J. C., et al. (2009) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390903372599 · Cited by 710 · cited 1×
“Nevertheless, complex interactions among heredity [23], epigenetic imprinting [24], lifestyle, feeding behavior [25], as well as environmental [26] and physiologic inflammatory factors [27,28] also contribute to the etiology of obesity.”
BackgroundMechanisms of nutritional and hormonal regulation of lipogenesis
Kersten, S. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve071 · Cited by 700 · cited 1×
“Activity of FAS, a key enzyme of de novo lipogenesis, is positively regulated in the post-prandial state by several hormones (such as insulin, ghrelin and T3) and nutrients (dietary lipid and carbohydrate derivatives) [109,110], and is an important contributor to obesity and NAFLD [20,111].”
BackgroundGut microbiota, obesity and diabetes
Patterson, E., Ryan, P. M., Cryan, J. F., Dinan, T. G., Ross, R. P., Fitzgerald, G. F., & Stanton, C. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133285 · Cited by 552
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice
Membrez, M., Blancher, F., Jaquet, M., Bibiloni, R., Cani, P. D., Burcelin, R. G., Corthesy, I., Macé, K., & Chou, C. J. (2008) · The FASEB Journal · doi:10.1096/fj.07-102723 · Cited by 493 · cited 3×
“This observation is all the more interesting since Adiponectin is a potent modulator of insulin sensitivity [43].”
BackgroundMarten, B., Pfeuffer, M., & Schrezenmeir, J. (2006) · International Dairy Journal · doi:10.1016/j.idairyj.2006.06.015 · Cited by 456
Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis.
Eckel, N., Meidtner, K., Kalle-Uhlmann, T., Stefan, N., & Schulze, M. B. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487315623884 · Cited by 405 · cited 1×
“There is also evidence refuting the notion that MHO subjects are totally protected from metabolic diseases [40].”
BackgroundThe Gut Microbiota Modulates Energy Metabolism in the Hibernating Brown Bear Ursus arctos
Sommer, F., Ståhlman, M., Ilkayeva, O., Arnemo, J. M., Kindberg, J., Josefsson, J., Newgard, C. B., Fröbert, O., & Bäckhed, F. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.026 · Cited by 370
Metabolic disturbances connecting obesity and depression
Hryhorczuk, C., Sharma, S., & Fulton, S. E. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00177 · Cited by 322
Medium‐Chain Triglycerides Increase Energy Expenditure and Decrease Adiposity in Overweight Men
St‐Onge, M., Ross, R., Parsons, W. D., & Jones, P. J. H. (2003) · Obesity Research · doi:10.1038/oby.2003.53 · Cited by 280 · cited 2×
“Human Decreased global adiposity, body fat, and whole-body subcutaneous adipose tissue loss, waist circumference; significantly lowered rate of variation of body fat percentage [127,130,134]”
BackgroundGut microbiota and energy balance: role in obesity
Blaut, M. (2015) · Proceedings of The Nutrition Society · doi:10.1017/s0029665114001700 · Cited by 232
Assunção, M. L., Ferreira, H. S., dos Santos, A. F., Cabral, C. R., & Florêncio, T. M. M. T. (2009) · Lipids · doi:10.1007/s11745-009-3306-6 · Cited by 174 · cited 4×
“The resulting metabolic syndrome defines a group of metabolic risk factors linked to health problems associated with overweight and obesity such as elevated visceral adiposity, larger waist circumference (>102 cm in men and >88 cm in women), hyper-triglyceridemia (>150 mg/dL) [5], reduced HDL (high density lipoprotein…”
BackgroundInfluentialShort sleep duration and its association with energy metabolism
Klingenberg, L., Sjödin, A., Holmbäck, U., Astrup, A., & Chaput, J. ‐. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.00991.x · Cited by 94
Circadian clocks, obesity and cardiometabolic function
Scott, E. M. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12518 · Cited by 25 · cited 1×
“Some contributing factors for obesity progression are: unfavorable genetic determinants [10], lack of physical activity [11], socio-economic status [1], circadian cycle disturbance [12], sleep”
Background
Cited by
Koliada, A., Syzenko, G., Moseiko, V., Budovska, L., Puchkov, K., Perederiy, V., Gavalko, Y., Dorofeyev, A., Romanenko, M., Tkach, S., et al. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1027-1 · Cited by 1,000
“Microbiota can also promote obesity and metabolic syndrome by inducing lowgrade inflammation [7, 10].”
BackgroundBeli, E., Yan, Y., Moldovan, L., Vieira, C. P., Gao, R., Duan, Y., Prasad, R., Bhatwadekar, A., White, F. A., Townsend, S. D., et al. (2018) · Diabetes · doi:10.2337/db18-0158 · Cited by 365
Napoleão, A., Fernandes, L., Miranda, C., & Marum, A. P. (2021) · Nutrients · doi:10.3390/nu13041302 · Cited by 103
Subramaniam, S., Elz, A., Wignall, A., Kamath, S., Ariaee, A., Hunter, A., Newblack, T., Wardill, H. R., Prestidge, C. A., & Joyce, P. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123614 · Cited by 45
Metadata
- Authors
- Rial, S., Karelis, A., Bergeron, K.-F., & Mounier, C.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2016-05-12
- Volume
- 8
- Issue
- 5
- Pages
- 281
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2371568955
- Cited by
- 127
- References
- 30
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.